Clinical trial
Efficacy and Safety of Radiofrequency Ablation of Malignant Pulmonary Nodules
NCT02629978 is registered in ClinicalTrials.gov with Chinese PLA General Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Efficacy and Safety of Radiofrequency Ablation of Malignant Pulmonary Nodules
- Lead sponsor
- Chinese PLA General Hospital
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- October 31, 2015
- Completion date
- October 31, 2020
- Enrollment
- 500 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.